Home / News / India News / Article / Covaxin's Phase 3 trials results likely next month: Bharat Biotech

Covaxin's Phase 3 trials results likely next month: Bharat Biotech

Raches Ella, who leads the Covid-19 projects at Bharat Biotech, tweeted that after submitting efficacy and 2-months of safety to Central Drugs Standard Control Organisation (CDSCO) in July, it is expected to instantly reach pre-print server. Peer review will take another 2-4 months

Listen to this article :
Photo for representational purpose

Photo for representational purpose

The results of third phase trials of India's first indigenously developed Covid-19 vaccine Covaxin are expected to be released next month.

Covaxin manufacturer Bharat Biotech said its service provider, IQVIA, has started final statistical analysis.

Trending Stories

Latest Photoscta-pos

Latest VideosView All

Latest Web StoriesView All

Mid-Day FastView All

Advertisement